Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/07/2000WO2000073427A2 Acetylcholinesterase-derived peptides and uses thereof
12/07/2000WO2000073416A1 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
12/07/2000WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000WO2000073346A1 Immunoconjugates having high binding affinity
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000073341A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073340A1 C-cam as an angiogenesis inhibitor
12/07/2000WO2000073339A1 NOVEL INTEGRIN αSUBUNIT AND USES THEREOF
12/07/2000WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000WO2000073337A1 Polymer conjugates of hedgehog proteins and uses
12/07/2000WO2000073336A1 Fimbrial proteins
12/07/2000WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073333A2 Ligand for cd7, and methods for use thereof
12/07/2000WO2000073332A1 Annexin derivatives with endogenous chelation sites
12/07/2000WO2000073331A2 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
12/07/2000WO2000073330A2 Method and compositions relating to insulin resistance disorders
12/07/2000WO2000073329A2 Uses of notch related genes
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073326A2 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073322A1 Human carbamyl phosphate synthetase i polymorphism and diagnostic and therapeutic methods relating thereto
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073320A1 A NOVEL CHEMOKINE OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
12/07/2000WO2000073316A2 Virus immunologic determinants
12/07/2000WO2000073302A1 Oxazaheterocycles as protease inhibitors
12/07/2000WO2000072895A1 Cell-coated supports
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072880A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072875A1 A method of prophylaxis and treatment and agents useful for same
12/07/2000WO2000072874A1 IMMOBILIZED LACTOFERRIN (Im-LF) ANTIMICROBIAL AGENTS AND USES THEREOF
12/07/2000WO2000072873A1 Freeze dried hgf preparations
12/07/2000WO2000072872A1 Keratinocyte growth factor-2 formulations
12/07/2000WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000WO2000072870A1 Compositions of a-beta peptide and processes for producing same
12/07/2000WO2000072869A1 Methods for producing 5'-nucleic acid-protein conjugates
12/07/2000WO2000072868A2 Peptides for therapeutic use
12/07/2000WO2000072867A2 Substantially oil-free cyclosporin compositions
12/07/2000WO2000072865A2 Antifungal combination use
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000WO2000072863A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them
12/07/2000WO2000072856A1 Fibrin sealants providing less inflammatory response and methods using same
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000072852A1 Prevention of post surgical adhesions using a fibrin monomer sealant
12/07/2000WO2000072851A1 Method of sterilizing
12/07/2000WO2000072842A1 Nutritional supplements
12/07/2000WO2000072830A1 Method of producing submicron particles of a labile agent
12/07/2000WO2000072742A2 Methods and materials for generating sh3 domains with tailored binding properties
12/07/2000WO2000072690A2 IMMOBILIZED LACTOFERRIN (Im-LF) ANTIMICROBIAL AGENTS AND USES THEREOF
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000WO2000050456A3 Covalently bridged insulin dimers
12/07/2000WO2000049937A3 Trpm-2 antisense therapy
12/07/2000WO2000048626A3 Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000046147A3 Therapeutic calcium phosphate particles and methods of manufacture and use
12/07/2000WO2000045790A3 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
12/07/2000WO2000045771A3 Suppression of transformation of cells by the transcription factor egr
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
12/07/2000WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/07/2000WO2000038708A9 Treatment and prevention of immune rejection reactions
12/07/2000WO2000032746A3 Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
12/07/2000WO2000026350A3 Coenzyme a-utilizing enzymes
12/07/2000WO2000024390A9 Method and composition for modulating amyloidosis
12/07/2000WO2000020589A9 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER
12/07/2000DE19927039A1 New peptide compounds including Immediate-Early 1 Protein fragments, useful for the production of vaccines against human cytomegaloviruses (HCMV) and diagnostics for the identification of HCMV infections
12/07/2000DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19924965A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/07/2000DE10027521A1 Verbesserung der Peyronie-Krankheit (Penisfibromatose) Improvement of Peyronie's disease (Penisfibromatose)
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2385822A1 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
12/07/2000CA2383254A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2378737A1 Adipocyte complement related protein homolog zacrp5
12/07/2000CA2377948A1 Annexin derivatives with endogenous chelation sites
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375850A1 Method and compositions relating to insulin resistance disorders
12/07/2000CA2375829A1 Keratinocyte growth factor-2 formulations
12/07/2000CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000CA2375779A1 Lyophilized hgf preparation
12/07/2000CA2375700A1 Polymer conjugates of hedgehog proteins and uses
12/07/2000CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000CA2375325A1 Uses of notch related genes
12/07/2000CA2375237A1 Method of sterilizing
12/07/2000CA2375123A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375095A1 Groel muteins with improved stability
12/07/2000CA2375050A1 T-bet compositions and methods of use thereof
12/07/2000CA2375049A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374990A1 C-cam as an angiogenesis inhibitor
12/07/2000CA2374897A1 Compositions of a-beta peptide and processes for producing same
12/07/2000CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity
1 ... 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 ... 3163